Best Plasmid DNA CDMOs in Europe

← All Plasmid DNA CDMOs Best Clean FDA History Commercial Scale

Region: USA Europe Asia

CDMOs tracked

Fully scored

With FDA records

FDA inspections

100

EMA/MHRA GMP certs

Warning letters

For European-manufactured plasmid dna programs, Charles River Laboratories, ReciBioPharm, and Richter BioLogics lead CDMO Signal's ranking of plasmid dna CDMOs with confirmed European manufacturing sites. Filtered from the global directory of 23 scored plasmid dna CDMOs to 11 with European facility presence. EU and UK manufacturing carry specific regulatory considerations for sponsors: EMA and MHRA GMP certification — which contribute directly to the Signal Score's Quality Compliance pillar — are typically required for material supplied to EU/UK trials or commercial markets, and Qualified Person (QP) release is a distinct process step that doesn't apply to US-only manufacturing. Rankings update as new inspection and certificate data enters the platform. Full methodology at cdmosignal.com/methodology.

Plasmid DNA is the upstream starting material for viral vectors, mRNA, and DNA therapeutics — which makes plasmid supply a frequent bottleneck for the entire advanced-therapy pipeline. Plasmid CDMOs run microbial (E. coli) fermentation, alkaline lysis, and chromatographic purification to GMP grade.

Selecting a plasmid CDMO turns on GMP vs research grade, supercoiled fraction and purity, fermentation scale, and lead time. The rankings below score each CDMO on FDA inspections, GMP certification, clinical activity, and capacity.

FDA inspection outcomes across these CDMOs: 8 NAI (no action), 13 VAI (voluntary action), 1 OAI (official action). Leading inspection & GMP sites: Germany (27), UNITED KINGDOM (23), United States (20), Austria (11), Belgium (11).

Last updated 2026-07-22. Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

#	CDMO	Signal Score	Quality	FDA · GMP	Capacity	Programs
1	CR Charles River Laboratories Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD	91.7	98.7	8 insp · 11 GMP	Limited	0 programs
2	RP ReciBioPharm Keele, UK · Sodertalje, SE	88.0	100.0	0 insp · 3 GMP	—	0 programs
3	RB Richter BioLogics Hamburg, Germany	82.9	100.0	0 insp · 9 GMP	—	0 programs
4	WK Wacker Biotech Jena, DE · Amsterdam, NL · San Diego, CA	81.6	100.0	0 insp · 13 GMP	—	0 programs
5	KE Kaneka Eurogentec Seraing, BE	80.3	100.0	0 insp · 4 GMP	—	0 programs
6	AA Ascend Advanced Therapies London, United Kingdom	78.1	100.0	0 insp · 1 GMP	—	0 programs
7	OX Oxford Biomedica Oxford, United Kingdom	77.1	100.0	0 insp · 13 GMP	Available	7 programs
8	Catalent Bagsværd, Denmark (operating under Novo Holdings)	76.5	79.3	11 insp · 35 GMP	—	0 programs
9	BM Biomay AG Vienna, Austria	76.2	98.7	2 insp · 11 GMP	—	0 programs
10	CA Catalent (Novo Holdings) Harmans, MD · Gosselies, BE	75.1	79.3	1 insp · 0 GMP	Available	0 programs
11	PF PlasmidFactory Bielefeld, Germany	56.5	—	—	—	0 programs
—	3P Biopharmaceuticals (now 3PBIOVIAN) Pamplona-Noáin, Spain	Profiled	—	—	—	0 programs
—	53Biologics Boecillo (Valladolid), Spain	Profiled	—	—	—	0 programs
—	Touchlight Hampton, United Kingdom	Profiled	—	—	—	0 programs
—	Pharmaron Biologics (Liverpool) Liverpool, United Kingdom	Profiled	—	—	—	0 programs

How we score CDMOs →

What to evaluate in a Plasmid DNA CDMO

GMP grade & purity

Confirm GMP (vs research/HQ) grade, supercoiled percentage, and residual host-cell DNA/RNA and endotoxin specs — these gate downstream vector and mRNA quality.

Fermentation scale & yield

Match fermentation scale and yield to your vector or mRNA demand. Ask about high-yield strains and whether scale-up is validated.

Lead time

Plasmid is a common critical-path bottleneck. Evaluate realistic queue and turnaround against your program timeline.

Regulatory track record

Cross-check FDA 483 history and EMA/MHRA GMP coverage — both shown above and on each profile.

EMA and MHRA regulatory considerations for European-manufactured programs

European manufacturing for biopharma programs typically requires EMA-recognized GMP certification (via the EudraGMDP database) for EU material and MHRA GMP certification for UK material — post-Brexit, these are separate credentials even for CDMOs operating in both. The Signal Score's Quality Compliance pillar weighs EMA + MHRA GMP certificate density directly, so European CDMOs with dense certification typically rank higher on this pillar. Sponsors should verify certificate coverage for the specific manufacturing activity (drug substance vs drug product, dosage form) at the specific facility being considered — GMP certificates are activity-scoped, not blanket.

QP release requirements and how they affect CDMO selection

Every batch of medicinal product supplied to the EU market must be released by a Qualified Person (QP) — a specific regulatory role with statutory responsibility. This adds a process step (and typically a specific QP-service arrangement) that US-only manufacturing does not require. CDMOs with European operations either have in-house QPs (typical for larger diversified players) or coordinate with external QP services. For sponsors running EU trials or supplying EU commercial markets, this is a non-negotiable requirement to plan for. Individual CDMO profile pages capture facility-level detail; QP arrangements specifically are usually confirmed at RFP stage rather than published.

Which European CDMOs also cover FDA (US) regulatory geography?

European CDMOs with US FDA inspection history — indicating US regulatory posture — are candidates for sponsors running programs in both jurisdictions. The Signal Score's Quality Compliance pillar includes FDA inspection classifications, so a European CDMO with a strong FDA record typically ranks higher on that pillar than a European-only competitor. Cross-check with the US region ranking — CDMOs appearing in both rankings have demonstrated regulatory posture across both jurisdictions, which reduces tech-transfer risk for global programs.

Plasmid DNA CDMOs — Frequently Asked Questions

Who are the top Plasmid DNA CDMOs?

By CDMO Signal's independent Signal Score, the top-ranked Plasmid DNA CDMOs include Charles River Laboratories, ReciBioPharm, Richter BioLogics. See the full ranked table above — scored on FDA, clinical, financial, and capacity data.

How many Plasmid DNA CDMOs have FDA inspection records?

CDMO Signal tracks 4 Plasmid DNA CDMOs with FDA inspection records and 100 EMA/MHRA GMP certificates across the group.

What should I look for in a plasmid DNA CDMO?

Confirm GMP grade and purity specs (supercoiled %, residual host DNA, endotoxin), fermentation scale and yield for your demand, realistic lead time, and a clean FDA and EMA/MHRA record.

Why is plasmid DNA supply often a bottleneck?

Plasmid is the starting material for viral vectors and mRNA, so a single GMP plasmid lot gates multiple downstream steps. Constrained GMP fermentation capacity and long queues make it a frequent critical-path item.

Related modalities

mRNA / LNP CDMOs Lentiviral Vector CDMOs AAV / Gene Therapy CDMOs

Other Modalities

AAV CAR-T Lentiviral Cell Therapy mRNA/LNP Biologics Oligo/ASO Adenoviral Gene Editing Exosome Recombinant Proteins ADC